Pharmaceutical manufacturers of Propranolol

The Ajinomoto Group has advanced its purpose from “Unlocking the power of amino acids to resolve the food and health issues” to “contributing to the well-being of all human beings, our society and our planet with ‘AminoScience’.” We consider well-being to mean health and happiness. Our advanced purpose therefore represents our commitment to achieving two outcomes by 2030 which are connected by food systems: to reduce our environmental impact by 50% and to help extend the healthy life expectancy of 1 billion people.

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

CTX is a rapidly expanding Indian manufacturer of APIs and Intermediates, conducting operations across 70 nations. Over the past five years, the focus has been on elevating the organization by unwaveringly serving the pharmaceutical industry. CTX holds accreditations from US FDA, EU GMP, PMDA Japan, and COFEPRIS Mexico cGMP. The core business approach of CTX Life Sciences is to become a global pharmaceutical and chemical industry partner while ensuring consistent supply of APIs and Intermediates, along with DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, and GMP Xlife Sciences.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

COSMA S. P. A. (established in 1977) and AMSA S. P. A. (established in 1953) are a pair of chemical facilities widely recognized globally and particularly valued in the occidental world and in the nations that adhere to the Pharmaceutical Inspection Convention (PIC). They are part of the CFM Group, a privately-owned company engaged in the fields of chemistry and pharmaceuticals since 1949

Società Italiana Medicinali Scandicci, known as S.I.M.S. srl, was established in Scandicci in 1937 by Mr Ugo Rangoni. During the 1950s and 1960s, it experienced growth in both production and personnel. In 1972, the first DMF (phenylbutazone) was presented to the FDA. The current API facility in Reggello has been operational since 1974 and has been regularly examined by the Agency ever since. Since the 1980s, the company has garnered increasing recognition in the field of custom-toll manufacturing through GMP status with major partners. The company has more than 20 APIs with registered DMF and, when applicable, the corresponding CEP.

Roche CustomBiotech offers an extensive array of products and services for the diagnostics, biotechnology, and pharmaceutical industries. Our range of offerings includes enzymes, coenzymes, substrates, PCR-based kits for rapid microbiological methods, as well as the Cedex HiRes and Cedex Bio HT Analyzers for monitoring cell growth and fermentation processes.

Mankind Pharma endeavors to support the community in promoting a healthy lifestyle by creating, formulating, marketing, and supplying cost-effective and easily accessible medications that meet critical medical requirements. Established in 1986, Mankind Pharma was formally incorporated as a company in 1991 and began operations as a fully-integrated pharmaceutical company in 1995. Presently, Mankind boasts a workforce of over 14,000 employees and is striving to achieve a revenue of $1 billion

Grace's Superior Chemical Manufacturing Services (FCMS) is a contract development and manufacturing organization (CDMO) in North America, providing extensive capabilities for the pharmaceutical, nutraceutical, and fine chemical sectors. With over 40 years of experience, we collaborate closely with our clients at every stage, from the laboratory to large-scale production. Additionally, we facilitate multinational regulatory compliance in both cGMP and non-cGMP sectors.

Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with dominant positions in lithium, bromine, and refining catalysts. We empower the potential of businesses in numerous critical industries worldwide, ranging from energy and telecommunications to transportation and electronics

The ACIC Group operates as a comprehensive pharmaceutical and fine chemical company, producing and supplying active pharmaceutical ingredients, offering contract manufacturing services, process development, regulatory services, clinical services, and finished dosage forms from cGMP and FDA inspected facilities. Its proven track record and dedication make it an excellent choice for pharmaceutical projects, with the ability to anticipate market and regulatory trends in regulated and semi-regulated markets. The ACIC service relationship is designed to be adaptable to individual needs, allowing for full customization. Additionally, ACIC offers multilingual communication and translation services in French, German, Spanish, Italian, Portuguese, Mandarin, and other languages. ACIC's Open World Service aims to provide more efficient solutions by offering a wider range of global choices, supporting clients in the transition from molecule to market. The company provides solutions in areas such as fine chemicals, marketing and sales, process research, formulation, site transfer, CRO services, electronic CTD format, sales and acquisition of facilities, process development, pilot scale-up, process optimization, manufacturing scale-up, production validation, global regulatory submission, regulatory interpretation, and patent application.